Jeremy Bender
2021
In 2021, Jeremy Bender earned a total compensation of $19.8M as Chief Executive Officer and President at Day One Biopharmaceuticals, a 618% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $313,800 |
|---|---|
| Option Awards | $13,756,228 |
| Salary | $523,021 |
| Stock Awards | $5,168,061 |
| Total | $19,761,109 |
Bender received $13.8M in option awards, accounting for 70% of the total pay in 2021.
Bender also received $313.8K in non-equity incentive plan, $523K in salary and $5.2M in stock awards.
Rankings
In 2021, Jeremy Bender's compensation ranked 337th out of 12,415 executives tracked by ExecPay. In other words, Bender earned more than 97.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 337 out of 12,415 | 97th |
Division Manufacturing | 100 out of 5,505 | 98th |
Major group Chemicals And Allied Products | 31 out of 2,375 | 99th |
Industry group Drugs | 27 out of 2,096 | 99th |
Industry Pharmaceutical Preparations | 15 out of 1,546 | 99th |
Source: SEC filing on April 28, 2022.
Bender's colleagues
We found two more compensation records of executives who worked with Jeremy Bender at Day One Biopharmaceuticals in 2021.